Attributable mortality of antibiotic resistance in gram-negative infections in the Netherlands: a parallel matched cohort study

• Published in: Clinical microbiology and infection Vol. 27; no. 5; pp. 742 - 749
• Main Authors: Rottier, Wouter C., Deelen, J.W. Timotëus, Caruana, Giorgia, Buiting, Anton G.M., Dorigo-Zetsma, J. Wendelien, Kluytmans, Jan A.J.W., van der Linden, Paul D., Thijsen, Steven F.T., Vlaminckx, Bart J.M., Weersink, Annemarie J.L., Ammerlaan, Heidi S.M., Bonten, Marc J.M.
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01.05.2021
• Subjects: Bacteraemia; Burden of antimicrobial resistance; Enterobacterales; Extended-spectrum beta-lactamase; Nonbacteraemic infection; Bacteraemia; Enterobacterales; Extended-spectrum beta-lactamase; Burden of antimicrobial resistance; Nonbacteraemic infection
• ISSN: 1198-743X; 1469-0691
• DOI: 10.1016/j.cmi.2020.07.014

Antibiotic resistance in Gram-negative bacteria has been associated with increased mortality. This was demonstrated mostly for third-generation cephalosporin-resistant (3GC-R) Enterobacterales bacteraemia in international studies. Yet, the burden of resistance specifically in the Netherlands and created by all types of Gram-negative infection has not been quantified. We therefore investigated the attributable mortality of antibiotic resistance in Gram-negative infections in the Netherlands. In eight hospitals, a sample of Gram-negative infections was identified between 2013 and 2016, and separated into resistant and susceptible infection cohorts. Both cohorts were matched 1:1 to non-infected control patients on hospital, length of stay at infection onset, and age. In this parallel matched cohort set-up, 30-day mortality was compared between infected and non-infected patients. The impact of resistance was then assessed by dividing the two separate risk ratios (RRs) for mortality attributable to Gram-negative infection. We identified 1954 Gram-negative infections, of which 1190 (61%) involved Escherichia coli, 210 (11%) Pseudomonas aeruginosa, and 758 (39%) bacteraemia. Resistant Gram-negatives caused 243 infections (12%; 189 (78%) 3GC-R Enterobacterales, nine (4%) multidrug-resistant P. aeruginosa, no carbapenemase-producing Enterobacterales). Subsequently, we matched 1941 non-infected controls. After adjustment, point estimates for RRs comparing mortality between infections and controls were similarly higher than 1 in case of resistant infections and susceptible infections (1.42 (95% confidence interval 0.66–3.09) and 1.32 (1.06–1.65), respectively). By dividing these, the RR reflecting attributable mortality of resistance was calculated as 1.08 (0.48–2.41). In the Netherlands, antibiotic resistance did not increase 30-day mortality in Gram-negative infections.